Table 4 HPV vaccine acceptability by young women
Taking for granted efficacy and safety of HPV vaccines: I would agree to receive the vaccine if | N | Strongly Agree | Somewhat Agree | Somewhat Disagree | Strongly Disagree |
|---|---|---|---|---|---|
Free of charge | |||||
18–25 years | 43 | 56 (41–71) | 35 (21–49) | 7 (0–15) | 2 (0–7) |
26–30 years | 34 | 41 (25–58) | 32 (17–48) | 15 (3–27) | 12 (1–22) |
Have to pay 100$ per dose | |||||
18–25 years | 39 | 28 (14–42) | 44 (28–59) | 23 (10–36) | 5 (0–12) |
26–30 years | 25 | 28 (10–46) | 56 (37–75) | 16 (2–30) | 0 (0–13) |
If recommended by physician | |||||
18–25 years | 43 | 79 (67–91) | 16 (5–27) | 5 (0–11) | 0 (0–14) |
26–30 years | 34 | 50 (33–67) | 32 (17–48) | 12 (1–23) | 6 (0–14) |